17 results about "Lycopus lucidus" patented technology

The invention discloses a plant lactobacillus. The plant lactobacillus has the characteristic of efficiently tolerating 30% (w / v) cistanche substrate. The invention also discloses a medicinal and edible composition consisting of 85 parts of cistanche deserticola, 5 parts of rehmannia, 5 parts of fructus alpiniae oxyphyllae and 5 parts of Chinese yam, the composition is fermented by using plant lactobacillus, and the cistanche deserticola fermentation liquor is prepared by adopting a multi-stage temperature fermentation process to ferment for 16 hours. A non-targeted metabonomics result shows that the phytobacterium plantarum activates an upstream channel for synthesis of phenylethanoid glycoside substances, and the abundance of forsythiaside B is increased by 133 times compared with that before fermentation. The fermentation liquor can achieve the functions of reproductive anti-aging, kidney protection and body endurance improvement by down-regulating COX-2a and TGF-beta-1 gene expression.

This invention provides a traditional Chinese medicine composition for the prevention and treatment of knee arthritis. The active ingredients, by weight, include: 15-25 parts of Salvia miltiorrhiza, 8-15 parts of Ligusticum chuanxiong, 12-20 parts of Angelica sinensis, 7-15 parts of Lycopus lucidus, 15-30 parts of Poria cocos, 8-15 parts of Placenta hominis, 18-30 parts of Clematis chinensis, 15-25 parts of Spatholobus suberectus, 25-40 parts of Paeonia lactiflora, 12-20 parts of Rehmannia glutinosa, and 8-15 parts of Glycyrrhiza uralensis. Using Salvia miltiorrhiza, Ligusticum chuanxiong, Angelica sinensis, Lycopus lucidus, Poria cocos, Placenta hominis, Clematis chinensis, Spatholobus suberectus, Paeonia lactiflora, Rehmannia glutinosa, and Glycyrrhiza uralensis as raw materials, this invention follows the principle of "principal, assistant, adjuvant, and guide" in traditional Chinese medicine. The combined use of these herbs can tonify the liver and kidneys, promote blood circulation and remove blood stasis, and has a good therapeutic effect on knee arthritis caused by liver and kidney deficiency and qi stagnation and blood stasis.

The application discloses a plant lactobacillus. The plant lactobacillus has the characteristics of high tolerance to 30% (w / v) cistanche matrix. The application also discloses a homologous medicinal and edible formula which is composed of 85 parts of cistanche, 5 parts of rehmannia root, 5 parts of yizhi kernel and 5 parts of yam. The formula is fermented by the plant lactobacillus, and a cistanche and yam fermented liquid is prepared by adopting a multi-stage temperature fermentation process for 16 hours. Non-targeted metabolomics results show that the plant lactobacillus activates the upstream pathway of phenylethanoid glycoside synthesis, and the abundance of forsythoside B is up-regulated by 133 times compared with that before fermentation. The fermented liquid can play the functions of reproductive anti-aging, kidney protection and body resistance improvement by down-regulating the expressions of COX-2a and TGF-beta-1 genes.

The invention relates to the field of traditional Chinese medicine, and discloses a traditional Chinese medicine composition for treating chronic prostatitis and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by mass: 5-15 parts of pericarpium citri reticulatae viride; 5-15 parts of szechwan chinaberry fruit; 5-15 parts of the root of three-nerved spicebush; 5-15 parts of radix angelicae dahuricae; 10-20 parts of herba lycopi; 10 to 20 parts of herba patriniae; 4 to 8 parts of frankincense; 4 to 8 parts of myrrh; 5 to 15 parts of rhizoma corydalis; 10 to 20 parts of caulis spatholobi; 5 to 15 parts of diverse wormwood herb; 10 to 20 parts of cowherb seed; 5-15 parts of radix curcumae; and 4-8 parts of fennel. The traditional Chinese medicine composition can significantly improve the symptoms of chronic prostatitis, regulate the syndromes of traditional Chinese medicine and improve the life quality of patients, and has good safety and patient compliance.

This invention belongs to the field of traditional Chinese medicine oral decoction preparation technology. Specifically, it relates to a method for preparing a stable and safe decoction of traditional Chinese medicine composition for hepatitis, jaundice virus, cirrhosis, and ascites. The decoction is prepared by decocting the following eleven traditional Chinese medicine components: 30g of raw Lysimachia christinae, 30g of Plantago asiatica, 30g of Poria cocos peel, 30g of Dioscorea opposita, 26g of Areca catechu peel, 16g of Salvia miltiorrhiza, 16g of Bupleurum chinense, 16g of Alisma plantago-aquatica, 16g of Astragalus membranaceus, 13g of Lycopus lucidus, and 10g of processed pangolin scales. When decocting, pour the mixture into a sterilized and cleaned porcelain medicine pot, add cold water and soak for 30 minutes. Bring to a boil over high heat, then simmer over low heat for 20 minutes. Turn off the heat and let it cool slightly before drinking. This is the medicine product. By combining classical traditional methods with modern decoction technology, the decoction of these eleven traditional Chinese medicines yields a traditional Chinese medicine preparation with significant effects and convenient administration. This formula features comprehensive regulation and enhancement. It selects herbs such as Lysimachia christinae, Plantago asiatica, Poria cocos, and Salvia miltiorrhiza, which have antibacterial, drainage, dampness-removing, anti-inflammatory, and blood-stasis-removing components for liver ascites. The combination of eleven Chinese herbs has anti-inflammatory, detoxifying, and dampness-removing effects, which are beneficial for treating liver ascites lesions, removing hepatitis, jaundice, tuberculosis, damp-heat accumulation, inflammation-induced ascites, enhancing immunity, and healing effects.

The invention discloses a method for extracting bamboo leaf flavonoid and preparing a bamboo leaf flavonoid health-care beverage and beverage, and particularly relates to a method for preparing the bamboo leaf flavonoid health-care beverage and beverage by using nine high-benefit bamboo varieties in southern China as raw materials. The high-temperature-resistant coating is prepared from the following raw materials in parts by weight. The components comprise 70 parts of flavonoid compounds and other effective active substances extracted from dry bamboo leaf fragments by adopting a complex enzyme-microwave method, 16 parts of polysaccharide extracted from hericium erinaceus by adopting a conventional hot water extraction method, 17 parts of effective active substances extracted from plumbago indica by adopting hot water, 9 parts of eurycoma longifolia, 26 parts of effective active substances of beautiful millettia roots and 15 parts of effective active substances of polygonatum kingianum. The bamboo leaf flavonoid health-care beverage and the bamboo leaf beverage integrate the nutrients and other effective components of the bamboo leaf flavonoid and the hericium erinaceus and plumbago indica extract liquor, become an excellent bamboo leaf flavonoid health-care beverage and the bamboo leaf beverage, and have the effects of eliminating various types of reactive oxygen free radicals and inhibiting lipid peroxidation after being drunk usually; the vitamin C can protect brain blood vessels, block nitrosation reaction and eliminate nitrous ammonia, and can resist fatigue and aging as vitamin C.

This invention belongs to the field of traditional Chinese medicine, specifically relating to a traditional Chinese medicine composition for treating hyperuricemia complicated with metabolic syndrome, its preparation method, and its application. The traditional Chinese medicine composition comprises the following components in parts by weight: Codonopsis pilosula 3-6 parts, Astragalus membranaceus 12-18 parts, Bupleurum chinense 1-5 parts, Citrus reticulata peel 1-5 parts, Citrus aurantium peel 3-6 parts, Scutellaria baicalensis 1-5 parts, Nelumbo nucifera leaf 3-6 parts, Crataegus pinnatifida 3-6 parts, Anemarrhena asphodeloides 12-18 parts, Coptis chinensis 1-3 parts, Polygonatum sibiricum 3-6 parts, Pueraria lobata 28-35 parts, Schisandra chinensis 1-5 parts, Smilax glabra 28-35 parts, Cimicifuga foetida 1-5 parts, processed chicken gizzard lining 5-10 parts, Lycopus lucidus 3-6 parts, Atractylodes lancea 3-6 parts, Phellodendron chinense 3-6 parts, and Liquidambar formosana 3-6 parts. The traditional Chinese medicine composition of this invention follows the theory of traditional Chinese medicine compatibility, and synergistically achieves the effects of strengthening the spleen and soothing the liver, resolving phlegm and drying dampness, clearing heat and removing blood stasis. By effectively reducing the levels of blood uric acid, triglycerides, systolic blood pressure and diastolic blood pressure, and regulating key indicators such as high-density lipoprotein, it significantly improves the clinical symptoms of patients with hyperuricemia and metabolic syndrome. Moreover, it has good safety in clinical application and no obvious adverse reactions.

The invention belongs to traditional Chinese medicines, and discloses a traditional Chinese medicine compound composition for treating diabetic nephropathy and a quality evaluation method thereof, and the traditional Chinese medicine compound composition comprises astragalus membranaceus, prepared rehmannia root, dogwood, poria cocos, gordon euryale seed, cherokee rose fruit, semen cuscutae, herba lycopi, salvia miltiorrhiza and rheum officinale. The traditional Chinese medicine composition can improve weight loss and blood sugar increase caused by diabetic nephropathy, effectively relieve renal dysfunction and kidney tissue pathological conditions, relieve the degree of pathological injuries such as inflammation and fibrosis in kidney tissue, and finally achieve the effect of treating diabetic nephropathy. The method comprises the following steps: detecting by adopting a high performance liquid chromatography, establishing a characteristic spectrum, obtaining 22 common characteristic peaks, identifying the characteristic peaks by adopting a high-resolution mass spectrum, selecting 7 characteristic components on the basis of the characteristic spectrum, and establishing a content determination method for simultaneously determining the 7 components. The traditional Chinese medicine composition has important significance for controlling the quality of the traditional Chinese medicine composition for treating diabetic nephropathy.

The present invention provides a method of manufacturing health functional food containing aloeswood, including: a material preparation step in which materials are prepared by washing each of aloeswood, mulberry Phellinus linteus, Houttuynia cordata Thunb., Saururus chinensis, green tea or puer tea, Stachys sieboldii, Lycopus lucidus Turcz., Agrimonia pilosa, and Panax notoginsengs, and then drying in the shade; a material pulverization step in which each of those, dried through the material preparation step, is pulverized; and a molding step in which, after the material pulverization step is completed, powders thereof are mixed to prepare a material mixture, honey is mixed, and the resulting mixture is molded into a desired shape.

This invention relates to the field of traditional Chinese medicine (TCM) technology and discloses a TCM composition for treating liver diseases. The composition, by weight, comprises at least the following ingredients: 10-14g of Salvia miltiorrhiza, 10-12g of Prunus persica, 10-12g of Rubia cordifolia, 13-17g of Lycopus lucidus, 13-17g of Polygonum cuspidatum, 10-12g of Cornus officinalis, 5-7g of Schisandra chinensis, 27-33g of Sedum sarmentosum, 27-33g of Atractylodes macrocephala, and 10-14g of Alisma plantago-aquatica. The preparation method of this TCM composition for treating liver diseases involves mixing the above ingredients, adding 400ml of water, bringing to a boil over high heat, and continuing to decoct for 30 minutes. The decoction is then filtered and extracted. Another method involves adding 400ml of water to the dregs, bringing to a boil over high heat, and continuing to decoct for 30 minutes. The decoction is then filtered and extracted. The two extractions are then combined. This traditional Chinese medicine composition for treating liver diseases is used to treat fatty liver hepatitis caused by blood stasis, toxin accumulation, dampness, spleen dysfunction, and liver yin deficiency. It has the effects of promoting blood circulation and detoxification, strengthening the spleen and promoting diuresis, and nourishing yin and softening the liver.

The invention discloses application of herba lycopi flavone or pharmaceutically acceptable salts or solvates thereof in preparation of medicines for preventing, delaying and / or treating heart aging and / or myocardial injury, and particularly discloses application of herba lycopi flavone or pharmaceutically acceptable salts or solvates thereof in preparation of medicines for preventing, delaying and / or treating heart aging and / or myocardial injury. The herba lycopi flavone disclosed by the invention has a structure as shown in a formula (I). The herba lycopi flavone disclosed by the invention can be used for improving heart function indexes of senescent heart, reducing the expression level of gamma-H2AX in senescent heart tissues and effectively improving myocardial fiber breakage and arrangement disorder of organisms. (I).

This invention belongs to the field of feed additive technology, and particularly relates to a feed additive that reduces antibiotic resistance genes in animal feces, its preparation method, and its application. The feed additive comprises the following components in the indicated mass ratios: rosmarinic acid 10-15%, 5-O-caffeoylshikimic acid 10-15%, Lycopus lucidus flavonoids 8-12%, tea polyphenols 7-10%, DL-α-tocopherol 7-10%, hydroxypropyl-β-cyclodextrin 22-28%, microcapsule wall material 18-22%, EDTA-2Na 0.8-1.2%, and citrate-sodium citrate buffer 1.5-2.2%. This feed additive not only exhibits clear antibacterial activity against Escherichia coli and Salmonella, but also improves the growth performance of weaned piglets, reduces the diarrhea rate in weaned piglets, and decreases the abundance of antibiotic resistance genes in their feces, showing promising application prospects.

The present invention provides a method of preparing aloeswood water, including: a material preparation step in which materials are prepared by washing each of aloeswood, Phellinus linteus, Houttuynia cordata Thunb., Saururus chinensis, green tea or puer tea, Stachys sieboldii, Lycopus lucidus Turcz., Agrimonia pilosa, and Panax notoginsengs, and then drying in the shade; a material pulverization step in which each of those, dried through the material preparation step, is pulverized; a boiling step in which, after the material pulverization step is completed, the powders thereof are mixed to prepare a material mixture, water is mixed, and the resulting mixture is heated and boiled; an infusing step in which, after the boiling step is completed, infusing is performed by cooling the boiled water; and a reduced pressure distillation step in which, after the infusing step is completed, the infused water is distilled under reduced pressure.

The invention provides an external compound preparation for gouty arthritis and a preparation method and application thereof, and relates to the technical field of external traditional Chinese medicine preparations. The external compound preparation comprises a traditional Chinese medicine active component and a pharmaceutically acceptable matrix, wherein the traditional Chinese medicine active ingredients comprise rheum officinale, radix paeoniae rubra, vinegar frankincense, vinegar myrrh, cassia twig, radix angelicae, herba lycopi, cacumen biotae, fructus gardeniae, notopterygium root, radix trichosanthis, wine-processed radix dipsaci, hot rhizoma drynariae, pseudo-ginseng powder, ligusticum wallichii, cortex moutan and kadsura root-bark. The external compound preparation is designed according to the core pathogenesis of damp-heat accumulation in traditional Chinese medicine, is obtained through compatibility of the raw materials, realizes multi-target collaborative intervention, and has the characteristics of quick effect, high safety and wide applicable crowd.

The invention relates to dianella endophytic fungi DER8 as well as extraction and application of active components of the dianella endophytic fungi DER8, and belongs to the technical field of biology. The invention provides a penicillium strain DER8 with the preservation number of GDMCC NO: 67082 aiming at the problems of chemical pesticide resistance and difficult acquisition of plant-derived antibacterial substances. The bacteriostatic preparation comprises a culture, a crude extract or the benzaldehyde compound, wherein the crude extract is prepared by bacterial strain activation, rice culture medium fermentation and sequential extraction of petroleum ether, dichloromethane and ethyl acetate; the compound is separated and purified from an ethyl acetate crude extract through silica gel column gradient elution, thin-layer chromatographic analysis, gel column chromatography and recrystallization. The invention also provides an extraction and purification method of the benzaldehyde compound. The preparation has a remarkable inhibiting effect on panax notoginseng alternaria, panax notoginseng root rot fungi, panax notoginseng colletotrichum and ralstonia solanacearum, the crude extract has excellent antioxidant activity, and the preparation is mainly used for preparing green bactericides and antioxidant products for preventing and treating plant diseases.

The invention belongs to the technical field of traditional Chinese medicine processing, and particularly relates to an auxiliary material composition for processing rhizoma cyperi, rhizoma cyperi decoction pieces as well as a processing method and application of the rhizoma cyperi decoction pieces. The research finds that the rhizoma cyperi decoction piece prepared by combining auxiliary materials including fennel, folium artemisiae argyi, herba lycopi, herba elsholtziae, fructus alpiniae oxyphyllae and semen raphani shows an excellent effect in the aspect of treating liver depression, qi stagnation and blood stasis; the rhizoma cyperi decoction pieces prepared by combining auxiliary materials including fennel, folium artemisiae argyi, herba lycopi, herba elsholtziae, fructus alpiniae oxyphyllae, semen raphani, brown sugar, fresh ginger, table salt and table vinegar show an excellent effect in the aspect of treating primary dysmenorrhea and threatened abortion metrorrhagia. Besides, by optimizing processing technological parameters, the scientificity and stability of the processing process are ensured, the processing technology after auxiliary material combination optimization of the thirteen-processed rhizoma cyperi is preliminarily explored, and a basis is provided for modern industrial improvement of the thirteen-processed rhizoma cyperi.

The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for preventing and / or treating ischemic eye diseases. The traditional Chinese medicine composition is prepared from 8 to 20 parts of rhizoma acori graminei, 8 to 20 parts of flos eriocauli, 5 to 15 parts of rhizoma chuanxiong, 5 to 15 parts of herba lycopi, 8 to 20 parts of radix astragali seu hedysari, 5 to 15 parts of radix angelicae sinensis, 5 to 15 parts of rhizoma pinelliae and 5 to 15 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the effects of promoting qi circulation, reducing phlegm, promoting blood circulation, dredging vessels, treating both symptoms and root causes, removing turbidity, removing toxicity, reinforcing qi, nourishing yin and the like, and can effectively prevent and / or treat ischemic eye diseases.